Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ciprofloxacin and amoxicillin exposure during febrile versus afebrile infection
2019-001240-21Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin and ciprofloxacin in bacterial disease (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoint: Area under the concentration-time curve (AUC). Started Jun 2019; status: active.
02
Drugs
amoxicillinciprofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2019-001240-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001240-21.